elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Drug repositioning
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Drug repositioning
RIS
0.000
(Research Intensity Score)
Papers
65
Top papers
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 · 1515 citations
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
2021 · 249 citations
Therapeutic innovation in drug repurposing: Challenges and opportunities
2025 · 45 citations
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
2021 · 176 citations
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
2020 · 239 citations
Newest papers
Recent Advances in Vitiligo Treatment
2026 · 3 citations
Glaucoma Drug Target Prioritisation Informs Disease-specific Therapeutic Potentials of Targeting SMAD4
2026 · 2 citations
Repurposing a Nonessential Amino Acid γ-Aminobutyric Acid To Treat Multidrug-Resistant Bacteria
2026 · 2 citations
Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer
2026
4-Hydroxytamoxifen suppresses the malignant progression of lung adenocarcinoma by inhibiting MAPK signaling pathway
2026
A sample from the 65 top papers behind Drug repositioning.
Create a free account to browse them all →
Drug repositioning's history
Research intensity over time
Explore Drug repositioning's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Drug repositioning's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link